№ lp_1_2_15147
File format: docx
Character count: 7679
File size: 26 KB
The document is a research study that evaluates various COPD Action Plans (APs) through internet and organizational searches, as well as randomized controlled trials, to identify and assess the effectiveness of these APs in managing chronic obstructive pulmonary disease.
Year:
2024
Region / City:
Global
Topic:
Chronic Obstructive Pulmonary Disease (COPD) Management
Document Type:
Research Study
Organization / Institution:
Various international medical organizations
Authors:
Schrijver J, Lenferink A, Brusse-Keizer M, et al.
Target Audience:
Healthcare professionals, researchers, policymakers
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / city:
Australia
Type of document:
Pharmaceutical submission / Public Summary Document
Regulatory authority:
Therapeutic Goods Administration (TGA)
Submitted by:
Generic Health Pty Ltd
Product:
Tiotropium Lupin 18 microgram powder for inhalation, LupinHaler device
Indication:
Chronic obstructive pulmonary disease (COPD)
Previous PBS listing:
Spiriva 18 microgram powder for inhalation, HandiHaler device
Submission type:
Category 4 (cost-minimisation comparison)
PBS item code:
8626BMP,NP
Maximum quantity:
1 pack, 30 units
Prescriber type:
Nurse Practitioners, Medical Practitioners
Restriction type:
Restricted benefit
Administrative advice:
Not to be used in combination with LAMA/LABA or SAMA; adherence to current inhaler technique to be reviewed at each clinical visit; diagnosis requires spirometry confirmation
Year:
2023
Region / City:
England
Topic:
Healthcare, Quality Standards
Document Type:
Policy document
Organization / Institution:
NHS England
Author:
General Practice Specification and Extraction Service (GPSES), NHS England
Target Audience:
Healthcare providers, Medical professionals
Period of Validity:
2023-2024
Approval Date:
01/04/2023
Date of Amendments:
01/08/2023
Contextual Description:
Policy document outlining business rules for COPD management under the Quality and Outcomes Framework for NHS England.
Year:
2019
Region / City:
United Kingdom
Topic:
Chronic Obstructive Pulmonary Disease (COPD), Oxygen Saturation
Document Type:
Guidance
Organization:
National Institute for Health and Care Excellence (NICE)
Author:
NICE
Target Audience:
General practitioners, healthcare professionals
Period of Validity:
Not specified
Approval Date:
August 2019
Date of Last Update:
N/A
Year:
Not specified
Region / City:
Not specified
Topic:
COPD, Medical Research Council score, Fibrinogen levels, Six-minute walking test, Medication costs, Probabilistic analysis
Document Type:
Scientific Analysis
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Researchers, Healthcare professionals, Clinicians
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Country:
China
Ethics Approval Number:
2023KYLL014
Scientific Field:
Genetic epidemiology
Research Topic:
Causal relationship between chronic obstructive pulmonary disease and lung adenocarcinoma
Study Design:
Two-sample Mendelian randomization study
Document Type:
Reporting checklist
Exposure:
Chronic obstructive pulmonary disease (COPD)
Outcome:
Lung adenocarcinoma (LUAD)
Data Sources:
GWAS dataset ebi-a-GCST90018807; GWAS dataset ebi-a-GCST004744; TCGA; GEO datasets GSE116959 and GSE76925
Sample Size:
57 LUAD patients, 11 healthy controls, 111 COPD cases, 40 smoking controls
Key Biomarkers:
FCRLA, GREM1, MMP9
Statistical Methods:
Inverse variance weighting (IVW), MR Egger, MR-PRESSO, LASSO regression, false discovery rate correction
Software:
R version 4.2.1; TwoSampleMR package; ggplot2
Diagnostic Criteria:
COPD defined by spirometry (FEV1/FVC < 0.7); LUAD confirmed by histopathology
Genetic Variant Selection Criteria:
Genome-wide significance threshold p < 5 × 10⁻⁸; LD pruning r² < 0.01
Core Mendelian Randomization Assumptions:
Relevance, independence, exclusion restriction
Document type:
Clinical correspondence letter
Medical topic:
COPD and bronchiectasis management
Medication:
Azithromycin
Purpose:
Recommendation to initiate azithromycin therapy to reduce exacerbations
Sender role:
Respiratory specialist
Recipient role:
General Practitioner
Patient category:
Patients with COPD or bronchiectasis experiencing exacerbations
Clinical objective:
Reduction in number of exacerbations within a 12-month period
Review schedule:
6 months after treatment initiation and additional follow-up months as specified
Prescribing status:
Amber Recommended
Prescribing guidance source:
Pan-Mersey Area Prescribing Committee
Response requirement:
GP confirmation or refusal within 14 days
Sections included:
Treatment dose and frequency, indication, review plan, GP decision section
Year:
2010
Organization:
Key Medical Resources, Inc.
Author:
Terry Rudd, RN, MSN
Type of Document:
Educational self-study module
Target Audience:
Nurses and healthcare professionals
Location:
Rancho Cucamonga, California, USA
Continuing Education Hours:
15.0
Certification:
California Board of Registered Nursing CEP#15122
Format:
Self-study with exam and evaluation form
Content Focus:
Asthma, COPD, respiratory assessment, lung function, pharmacology
Year:
2021
Study:
Global Burden of Disease Study 2021 (GBD 2021)
Topic:
Epidemiological modeling and data sources for COPD incidence and mortality
Document type:
Technical nomenclature and methodological description
Field:
Epidemiology and public health
Model:
Age–Period–Cohort (APC) model
Data source system:
Global Health Data Exchange (GHDx)
Database:
Causes of Death (CoD) database
Modeling tools:
DisMod-MR; MR-BRT (Bayesian regularized model with temporal smoothing)
Geographic coverage:
204 countries and territories
Health condition:
Chronic Obstructive Pulmonary Disease (COPD)
Data source types:
surveys, censuses, vital registration, surveillance systems, cancer registries, police records, sibling history, survey/census data, minimally invasive tissue sample diagnoses
Reference parameters:
reference age group (a0), reference period (p0), reference cohort (c0)
Statistical measures:
Net Drift, Age Deviations, Period Deviations, Cohort Deviations, Longitudinal Age Curve, Period Rate Ratios, Cohort Rate Ratios, Local Drifts
Data access platform:
Global Health Data Exchange citation tool
File format available:
CSV metadata export
Outlier criteria:
exclusion of implausible values, conflicts with age or temporal patterns, and inconsistencies with comparable data sources
Year:
2026
Region / City:
Multicenter, unspecified locations
Topic:
Chronic Obstructive Pulmonary Disease
Document Type:
Clinical Study Supplement
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Clinical researchers and healthcare professionals
Study Phase:
Not specified
Inclusion Criteria:
Adults aged 40–80 with COPD, stable maintenance therapy, capable of performing spirometry and following study procedures
Exclusion Criteria:
Recent severe infections or surgeries, significant comorbidities, prohibited medication use, pregnancy or breastfeeding, recent participation in other trials
Prohibited Medications:
Systemic or inhaled corticosteroids, certain antibiotics, leukotriene inhibitors, theophylline, PDE4 inhibitors, terbutaline, nebulized COPD medications, oral β2-agonists
Study Visits:
Screening (visit 1), baseline and dosing (visit 2), mid-study assessment (visit 3), end-of-treatment assessment (visit 4), follow-up call post-treatment
Assessment Tools:
CAT, mMRC Dyspnea Scale, spirometry, vital signs, physical examination
Treatment Duration:
12 weeks
Compliance Monitoring:
Dispensed medication retrieval and assessment at visits 3 and 4
Year:
2010–2011
Region:
United Kingdom, England
Subject:
Telehealth, Chronic Obstructive Pulmonary Disease (COPD), Health Economics
Document type:
Research Study / Pilot Programme Report
Organization:
National Health Service Direct (NHSD)
Authors:
Not specified
Target population:
Patients with chronic obstructive pulmonary disease (COPD)
Study sites:
Two Primary Care Trusts (PCT1, PCT2)
Participants:
321 enrolled, 227 included in final analysis
Intervention:
Remote patient monitoring / telehealth
Outcome measures:
Cost-effectiveness, resource utilization, hospital admissions, length of stay
Data collection period:
12 months before, immediately before, and during monitoring
Keywords:
telehealth, telemedicine, cost-effectiveness, remote patient monitoring
Year:
2018
Region / city:
Regional Victoria
Topic:
Pathophysiology, Pharmacology, COPD, Pneumonia
Document type:
Case report
Organization / institution:
CRICOS Provider No. 00103D
Author:
Not specified
Target audience:
Healthcare professionals, Medical students
Action period:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Year:
2026
Region:
West Yorkshire, UK
Subject:
Health communication / Patient engagement
Document type:
Template messages
Organization:
West Yorkshire Health Service
Target audience:
Patients with Asthma or COPD, parents/carers of children with Asthma
Platforms referenced:
Google Play, Apple App Store
Conditions addressed:
Asthma, COPD
Message length:
Short (≤160 characters), Long (≤300 characters)
Note:
Year
Topic:
Self-Assessment, Education
Document Type:
Educational Handout
Target Audience:
Educators, Students
Contextual description:
This document is an educational handout providing reflective questions and self-assessment strategies for educators to apply in elementary and secondary school settings.
Year:
2025
Region / city:
Sudan
Topic:
Sexual Exploitation and Abuse, Gender-Based Violence, Child Protection
Document Type:
Action Plan
Author:
United Nations Children’s Fund (UNICEF)
Target Audience:
Humanitarian and development actors, implementing partners, organizations involved in child protection and gender-based violence
Period of validity:
March 2025
Approval Date:
March 2025
Date of amendments:
N/A
Context:
This document outlines a detailed action plan to address sexual exploitation and abuse/sexual harassment risks within the context of the Sudan Emergency Crisis Response Safety Net Project (SANAD), focusing on mitigation strategies and survivor support mechanisms.
Year:
2021
Region / City:
Laos
Theme:
COVID-19 response, business recovery, trade facilitation, private sector support
Document Type:
Environmental and Social Action Plan (ESAP)
Organization:
Ministry of Industry and Commerce (MoIC)
Author:
World Bank
Target Audience:
Government, private sector, stakeholders involved in business development and trade
Period of Implementation:
2021-2023
Approval Date:
April 19, 2021
Date of Revisions:
Ongoing (as required)
Organization:
Action Africa Help-International (AAHI)
Program location:
South Sudan
Document type:
Job application form
Purpose:
Application for advertised employment positions
Target audience:
Job applicants
Submission requirements:
Completed form, motivation letter, academic documents, national ID or passport
Language of completion:
English
Format requirements:
Block letters or clear handwriting in blue ink
Related documents:
Motivation letter, academic certificates, identification documents
Employment scope:
National and international applicants
Application condition:
Mandatory for all advertised positions
Source of vacancies:
Advertisements issued by AAHI
Application status note:
Completion does not guarantee shortlisting or selection
Year:
2026
Institution:
Nova Southeastern University, Ft. Lauderdale
Course:
Neuromuscular Systems II
Credits:
2
Duration:
12 weeks, first semester of third year
Contributors:
Suzana Simoes PT, DPT, NCS; Kim B. Smith PT, DPT; Jennifer Canbek, PT, PhD, NCS
Target audience:
Physical therapy students
Activity type:
Laboratory learning activity with volunteer patients
Focus:
Clinical decision making using ICF model for Parkinson’s disease
Learning objectives:
Assessment of PD cases, development of PT problem list, formulation of patient-centered plan of care, implementation of treatment interventions, evaluation of treatment outcomes
Materials:
Assigned readings from Schenkman & McCulloch (2002), Schenkman et al. (2010)
Methods:
Lab sessions with patient volunteers, outcome measures, treatment sessions, video documentation, SOAP note assignments
Assessment:
Rubric-based evaluation of outcome measures, ICF model application, problem list, plan of care, goals, treatment, and documentation
Year:
2019
Region / City:
Joplin, Missouri
Theme:
Community Development, Housing, Infrastructure
Document Type:
Action Plan
Agency / Organization:
City of Joplin, Planning, Development and Neighborhood Services
Author:
City of Joplin
Target Audience:
Local Government, Community Development Organizations
Period of Validity:
Fiscal Year 2019
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2023
Region / city:
Somalia
Topic:
Sexual Exploitation, Abuse, and Harassment Prevention
Document type:
Action Plan
Organization / institution:
Ministry of Labor & Social Affairs (MOLSA), Federal Government of Somalia
Author:
N/A
Target audience:
Project Implementing Committee, project workers, stakeholders in Somalia
Effective period:
Ongoing, from December 2023
Approval date:
December 2023
Amendment date:
N/A
Note:
Contextual Description
Year:
2023
Region / City:
Jefferson County, Colorado
Document Type:
Community engagement report
Organization:
Jefferson County Open Space (JCOS)
Audience:
General public and park visitors
Topics:
Forest health, wildfire mitigation, habitat restoration, trail and trailhead improvements, visitor management
Event Date:
June 14, 2023
Number of Participants:
17 attendees, 3 online views